Northwire Canada EditionFriday, July 10, 2026
Northwire
S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0% S 0.165 +37.5% NNX 0.035 +0.0% ABX 52.05 −0.3% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.32 +12.1% TUNG 1.73 +2.4% LGO 1.00 −3.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.50 +1.1% SGZ 0.040 −11.1% GRSL 0.307 −3.9% DEX 0.380 −1.3% WMS 0.040 +0.0%
Earnings Routine +

Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales

Vext Scales Ohio Operations While Tax Liabilities Loom Over Cash Position

Executive Summary
  • Q1 2026 Financial Performance: Revenue of $12.2 million (up 5.2% YoY), Gross Profit doubled to $5.5 million with a 45.4% margin, and Adjusted EBITDA rose 73% sequentially to $3.6 million.
  • Profitability Improvement: Net loss narrowed by 73.2% year-over-year to $(0.9) million; Operating cash flow was positive at $1.62 million for the quarter.
  • Operational Strategy: Ohio platform drove growth with revenue up 34% YoY across five dispensaries; Arizona cultivation exit in Eloy is on track for completion by end of Q2 2026 to reduce fixed costs.
  • Tax Liability Risk: Uncertain Tax Position (UTP) liability increased to $10.6 million as of March 31, 2026, up from $8.1 million at year-end 2025; reclassified $2.5 million of income tax payable to UTP.
  • Cash Position: Cash position at quarter-end was $5.5 million with a cash flow margin of 13%.
Material Impact
  • Execution Confirmed: The sequential jump in Adjusted EBITDA from Q4's $2.1 million to Q1's $3.6 million confirms the cost-saving measures associated with the Arizona cultivation exit are materializing faster than expected, supporting operational efficiency.
  • Growth Deceleration Concern: Year-over-year revenue growth slowed significantly to 5.2% in Q1 compared to 43% in FY 2025 and 41% in Q3 2025; this suggests the Ohio retail expansion may be approaching saturation or facing market headwinds before hitting the state license cap.
  • Hidden Tax Risk: The UTP liability of $10.6 million exceeds the company's current cash position ($5.5 million); while currently non-cash, a negative resolution could force immediate dilution or debt issuance, posing a significant downside risk not fully priced in by the market.
  • Routine Nature: Given the Q4 2025 announcement of the Arizona pivot and Ohio expansion targets, these results are largely consistent with prior guidance rather than representing an unexpected breakthrough; the revenue slowdown is a negative deviation from previous growth rates but does not alter the core business model immediately.
VEXT · Price
Company Overview
  • Business Model: Vertically integrated cannabis operator focusing on retail dispensaries and cultivation in Ohio and Arizona.
  • Flagship Project: Expansion of the Ohio retail footprint from five to eight dispensaries (state cap) by early 2027, supported by the Jackson cultivation facility expansion.
  • Strategic Pivot: Exiting high-cost indoor cultivation in Eloy, Arizona, to reduce fixed costs and focus on wholesale sourcing for remaining Phoenix-area stores.
  • Regulatory Environment: Operating under Ohio's eight-dispensary cap; monitoring DEA rescheduling impacts (Schedule III) which has not yet been reflected in financial statements as a non-adjusting event.
Read the original news release →

More from Vext Science Inc.